Synthesis reveals new thiazolidines from non-toxic materials, highlighting their potential for pharmaceuticals.
The diverse biological activity of heterocyclic compounds makes them one of the most important areas of pharmaceuticals and organic synthesis. In this work, a synthesis of new hetarylquinolines containing thiazolidine and dihydrothiazole rings was carried out on the basis of 2-{1-[2-methyl-4-(methylthio)-quinolin-3-yl]propan-2-ylidene}hydrazinocarbothioamides substituted in the benzene ring. The synthesis was conducted using readily available and non-toxic starting materials, ensuring a practical and accessible methodology. The results of this work may serve as a foundation for further studies aimed at exploring the biological and applied potential of these compounds.
No takes yet. Share an insight, caveat, or question.
I. L. Aleksanyan (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: